Höffler J, Trenckmann U, Graf von der Schulenburg J M
Westfälische Klinik Gütersloh, Universität Witten/Herdecke.
Fortschr Neurol Psychiatr. 2000 Apr;68 Suppl 1:S7-12.
This paper presents a survey of economic analyses of schizophrenia in Germany. A recently published cost-of-illness study demonstrates the high financial burden to society caused by the disease. Ambulatory care and medication were remarkably less costly than in-patient treatment. Several other studies show that continuous in-patient treatment is less cost-effective than complementary care in the community. Two pharmaco-economic models evaluate drugs with special focus on long-term treatment. Drugs with better compliance rates seem to produce savings in the health care system by less hospital admissions, even if the drug is more expensive than other medication. In addition to the survey the problems of economic analysis of psychiatric disorders in Germany are discussed. There are difficulties caused by the structure of the German health care system. Other problems emerge from the measurement of outcomes, effectiveness, utilities and quality of life in psychiatric disorders.
本文介绍了德国对精神分裂症的经济分析调查。最近发表的一项疾病成本研究表明，该疾病给社会带来了高昂的经济负担。门诊护理和药物治疗的成本明显低于住院治疗。其他几项研究表明，持续住院治疗的成本效益低于社区补充护理。两个药物经济学模型对药物进行了评估，特别关注长期治疗。即使药物比其他药物更昂贵，但依从率更高的药物似乎可以通过减少住院次数在医疗保健系统中节省费用。除了该调查外，还讨论了德国精神疾病经济分析的问题。德国医疗保健系统的结构造成了一些困难。其他问题则源于精神疾病中结果、有效性、效用和生活质量的衡量。
